Ascentage Pharma Group International is a clinical-stage biopharmaceutical company focused on developing novel therapies for cancers and other life-threatening diseases. The company has commercialized olverembatinib in China, a BCR-ABL inhibitor approved by China's NMPA for certain leukemia indications. It conducts operations primarily in China and the United States, with multiple drug candidates in clinical and preclinical development stages.
52 total filings indexed. 52 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0002023311 |
| Ticker | AAPG |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | E9 |
| Website | https://www.ascentagepharma.com |
| Listed | 2025-01-24 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/AAPG (~200 tokens, structured JSON with cryptographic provenance)